Timothy Block
Directeur/Bestuurslid bij HEPION PHARMACEUTICALS, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Timothy Block
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 26-11-2013 | - |
| Independent Dir/Board Member | 26-11-2013 | - | |
| Hepatitis B Foundation | Oprichter | - | - |
| President | - | - | |
| Drexel University College of Medicine | Corporate Officer/Principal | - | - |
| Pennsylvania Biotechnology Center of Bucks County | Algemeen Directeur | - | - |
| President | - | - | |
| Baruch S. Blumberg Institute | Oprichter | - | - |
| President | - | - | |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Consultant / Adviseur | - | - |
| Oprichter | - | - |
Loopbaan van Timothy Block
Eerdere bekende functies van Timothy Block
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Founder | 4 |
| President | 3 |
| Director/Board Member | 2 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| Hepatitis B Foundation | |
| Pennsylvania Biotechnology Center of Bucks County | |
| Baruch S. Blumberg Institute | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
Hatch Biofund Management LLC
Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
- Beurs
- Insiders
- Timothy Block
- Ervaring
